These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

664 related articles for article (PubMed ID: 30107892)

  • 1. [Melatonin: Physiological and pharmacological aspects related to sleep: The interest of a prolonged-release formulation (Circadin
    Quera-Salva MA; Claustrat B
    Encephale; 2018 Dec; 44(6):548-557. PubMed ID: 30107892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged-release formulation of melatonin (Circadin) for the treatment of insomnia.
    Lemoine P; Zisapel N
    Expert Opin Pharmacother; 2012 Apr; 13(6):895-905. PubMed ID: 22429105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Controlled release melatonin (Circadin) in the treatment of insomnia in older patients: efficacy and safety in patients with history of use and non-use of hypnotic drugs].
    Zisapel N
    Harefuah; 2009 May; 148(5):337-41, 348. PubMed ID: 19630367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of prolonged release melatonin in insomnia patients aged 55-80 years: quality of sleep and next-day alertness outcomes.
    Wade AG; Ford I; Crawford G; McMahon AD; Nir T; Laudon M; Zisapel N
    Curr Med Res Opin; 2007 Oct; 23(10):2597-605. PubMed ID: 17875243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melatonin and melatonergic drugs on sleep: possible mechanisms of action.
    Srinivasan V; Pandi-Perumal SR; Trahkt I; Spence DW; Poeggeler B; Hardeland R; Cardinali DP
    Int J Neurosci; 2009; 119(6):821-46. PubMed ID: 19326288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lasting treatment effects in a postmarketing surveillance study of prolonged-release melatonin.
    Hajak G; Lemme K; Zisapel N
    Int Clin Psychopharmacol; 2015 Jan; 30(1):36-42. PubMed ID: 25054634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of melatonin in the regulation of human circadian rhythms and sleep.
    Cajochen C; Kräuchi K; Wirz-Justice A
    J Neuroendocrinol; 2003 Apr; 15(4):432-7. PubMed ID: 12622846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged-release melatonin improves sleep quality and morning alertness in insomnia patients aged 55 years and older and has no withdrawal effects.
    Lemoine P; Nir T; Laudon M; Zisapel N
    J Sleep Res; 2007 Dec; 16(4):372-80. PubMed ID: 18036082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melatonin: Physiological effects in humans.
    Claustrat B; Leston J
    Neurochirurgie; 2015; 61(2-3):77-84. PubMed ID: 25908646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melatonin prolonged release: in the treatment of insomnia in patients aged ≥55 years.
    Lyseng-Williamson KA
    Drugs Aging; 2012 Nov; 29(11):911-23. PubMed ID: 23044640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged release melatonin in the treatment of primary insomnia: evaluation of the age cut-off for short- and long-term response.
    Wade AG; Crawford G; Ford I; McConnachie A; Nir T; Laudon M; Zisapel N
    Curr Med Res Opin; 2011 Jan; 27(1):87-98. PubMed ID: 21091391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melatonin for primary insomnia?
    Drug Ther Bull; 2009 Jul; 47(7):74-7. PubMed ID: 19567841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of melatonin for the treatment of insomnia.
    Zisapel N
    Biol Signals Recept; 1999; 8(1-2):84-9. PubMed ID: 10085468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melatonin in medically ill patients with insomnia: a double-blind, placebo-controlled study.
    Andrade C; Srihari BS; Reddy KP; Chandramma L
    J Clin Psychiatry; 2001 Jan; 62(1):41-5. PubMed ID: 11235927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Melatonin receptor agonist].
    Uchiyama M
    Nihon Rinsho; 2015 Jun; 73(6):1017-22. PubMed ID: 26065135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The physiology and pharmacology of melatonin in humans.
    Geoffriau M; Brun J; Chazot G; Claustrat B
    Horm Res; 1998; 49(3-4):136-41. PubMed ID: 9550114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Melatonin--a natural hypnotic?].
    Saletu B
    Wien Klin Wochenschr; 1997 Oct; 109(18):714-21. PubMed ID: 9441514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Melatonin in humans: a biochemical marker of the circadian clock and an endogenous synchronizer].
    Claustrat B; Geoffriau M; Brun J; Chazot G
    Neurophysiol Clin; 1995; 25(6):351-9. PubMed ID: 8904197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nocturnal 6-sulfatoxymelatonin excretion in insomnia and its relation to the response to melatonin replacement therapy.
    Leger D; Laudon M; Zisapel N
    Am J Med; 2004 Jan; 116(2):91-5. PubMed ID: 14715322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of sleep disorders and melatonin.
    Xie Z; Chen F; Li WA; Geng X; Li C; Meng X; Feng Y; Liu W; Yu F
    Neurol Res; 2017 Jun; 39(6):559-565. PubMed ID: 28460563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.